Speciality-chemicals company with a distribution arm importing/trading chemicals (resorcinol, isophthalic acid, ethanolamines, meta cresol) and a Jhagadia, Gujarat plant manufacturing acrylamide and polyacrylamide products.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 62 | 88 | 117 | 122 | 140 | 148 | 150 | 164 |
| Borrowings | 23 | 17 | 14 | 5 | 4 | 11 | 8 | 1 |
| Other Liabilities | 51 | 37 | 40 | 30 | 43 | 50 | 50 | 37 |
| Total Liabilities | 141 | 147 | 176 | 162 | 193 | 214 | 213 | 208 |
| AssetsFixed Assets | 37 | 35 | 37 | 40 | 41 | 39 | 46 | 50 |
| CWIP | 2 | 7 | 8 | 8 | 7 | 9 | 6 | 2 |
| Investments | 0 | 0 | 0 | 0 | 12 | 0 | 10 | 20 |
| Other Assets | 102 | 105 | 130 | 114 | 132 | 166 | 152 | 135 |
| Total Assets | 141 | 147 | 176 | 162 | 193 | 214 | 213 | 208 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 11 | 17 | 10 | 15 | 23 | 17 | -13 | 45 |
| Cash from Investing | 0 | -7 | -5 | -6 | -12 | -10 | 12 | -26 |
| Cash from Financing | -9 | -9 | -5 | -4 | -11 | -5 | -8 | -18 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 10 | 10 | 10 | 15 | 17 | 14 | -16 | 38 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (30.2×) and current (22.0×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 41.5% growth and a 22× exit, ₹97 only delivers your return if you pay ₹271. The price is currently baking in 18% growth.
EPS grows 41.5%/yr for 5 years, then fades to 6% over 2, exits at 22×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 41.5% | 6.23 |
| FY28 | 41.5% | 8.81 |
| FY29 | 41.5% | 12.47 |
| FY30 | 41.5% | 17.64 |
| FY31 | 41.5% | 24.96 |
| FY32 | 23.8% ·fade | 30.89 |
| FY33 | 6.0% ·fade | 32.74 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.